I Basics -- 1 Anatomy and pathology of the peritoneum -- 2 Pharmacovigilance of topical chemotherapy in the peritoneum -- II Diagnostics and natural course -- 3 Imaging diagnostics of tumors of the peritoneum -- 4 Role of laparoscopy in the diagnosis of tumors of the peritoneum -- 5 Scoring systems for CRS and HIPEC -- 6 Natural course of peritoneal carcinomatosis -- III Therapy options of systemic therapy -- 7 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the upper GI tract -- 8 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the lower GI tract including appendiceal carcinoma -- IV Treatment options for surgical cytoreduction -- 9 Procedures of parietal and visceral peritonectomy in the upper abdomen -- 10 Technique of visceral and parietal peritonectomy in the lower abdomen -- 11 Procedures of parietal and visceral peritonectomy interenterically -- 12 Cytoreduction - preparation devices -- V therapy options of intraperitoneal therapy and experimental approaches -- 13 Application of IPC, HIPEC and PIPAC -- 14 Cytokine-induced senescence: an experimental therapy for peritoneal tumors -- 15 Mechanism of action and experimental and clinical data on regional hyperthermia -- 16 HIPEC in childhood -- VI Potentially curative approach -- 17 Importance of intraperitoneal chemotherapy as a prophylaxis after curative resection of a gastrointestinal carcinoma -- 18 Indication of CRS and HIPEC in Pseudomyxoma peritonei -- 19 Significance of CRS and HIPEC in mesothelioma -- 20 Indication of CRS and HIPEC in peritoneal metastatic gastric carcinoma -- 21 Indication of CRS and HIPEC in peritoneal metastases of colorectal carcinomas -- 22 Indication of CRS and HIPEC in peritoneal metastases of ovarian cancer -- 23 Indication of CRS and HIPEC in peritoneal metastases of NET and small intestinal carcinomas -- 24 Indication of CRS and HIPEC in peritoneal metastases of pancreatic carcinomas -- 25 Indications of CRS and HIPEC in Incidentally Detected Peritoneal Carcinomatosis -- VII VII Palliative treatment attempt of advanced peritoneal metastasis -- 26 Importance of systemic chemotherapy in advanced peritoneal metastasis -- 27 Importance of PIPAC in advanced peritoneal metastasis -- VIII Complications in the Palliative Chemotherapy of Peritoneal Cancer -- 28 Complications in the Palliative Chemotherapy of Peritoneal Cancer -- 29 Cytoreductive surgery for complications of peritoneal carcinomatosis -- 30 IPEC, HIPEC, Bidirectional Chemotherapy and Immunotherapy in Aggressive Peritoneal Metastasis -- IX Perioperative treatment and prophylaxis of treatment related complications -- 31 Preoperative Management: Risk Assessment, Conditioning, Nutritional Aspects, Special Preparation, Including Bowel -- 32 Safety Considerations for Intraoperative Use of Cytostatic Agents -- 33 Preventing Complications of Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy -- 34 Nutritional Concepts in Patients with Peritoneal Tumors -- 35 Perioperative management -- X Quality of life -- 36 Quality of life at CRS and HIPEC -- 37 PIPAC Therapy and Quality of Life -- XI Recurrent diesease -- 38 Follow-Up to Prevent Recurrence of Peritoneal Malignancies -- 39 Localization of Localization of Peritoneal Tumor Recurrence -- 40 Treatment Options for Peritoneal Tumor Recurrence -- XII Environmental Aspects -- 41 Importance of Psycho-Oncology for Tumors of the Peritoneum -- 42 Nursing Aspects of Peritoneal Surface Malignancy -- XIII Guidelines and centres -- 43 Guideline preparation and center development for the treatment of peritoneal tumors in Germany -- 44 Guideline preparation and center development for the treatment of peritoneal tumors in Switzerland -- Service part -- 45 Checklists for the treatment of tumors of the peritoneum. Framework SOP -- Index.